Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–4 of 4 results
Advanced filters: Author: Kailan Sierra-Davidson Clear advanced filters
  • The clinical utility of immune checkpoint inhibitors is limited by immune-related adverse events (irAEs); understanding the mechanisms of irAE development is thus crucial. A study reports that IL-17A-expressing CD4+ T cells were elevated at irAE onset and provides proof of concept for using IL-17A blockade to improve irAEs in two patients.

    • Kailan Sierra-Davidson
    • Genevieve M. Boland
    News & Views
    Nature Cancer
    Volume: 5, P: 1289-1291
  • Fifty-five percent of individuals vaccinated with an attenuated Plasmodium falciparum sporozoite vaccine remained without parasitemia after controlled human malaria infection one year later; immune correlate analysis in humans and non-human primates suggest a role for liver-resident T cells.

    • Andrew S Ishizuka
    • Kirsten E Lyke
    • Robert A Seder
    Research
    Nature Medicine
    Volume: 22, P: 614-623
  • In this Perspective, Holder et al. discuss the limitations of current predictive biomarkers of response to immune checkpoint inhibitors and the need to further explore static, dynamic and patient-specific biomarkers using novel tools, such as machine learning and consortia-level initiatives.

    • Ashley M. Holder
    • Aikaterini Dedeilia
    • Genevieve M. Boland
    Reviews
    Nature Reviews Cancer
    Volume: 24, P: 498-512